Valneva SE

NASDAQ: VALN
Share price (12/20/24): $3.99
Market cap (12/20/24): $277 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022 – amended

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Prospectus supplement with pricing info

Initial registration of new securities for foreign issuers

Ownership Filter

Bpifrance Participations SA

Deep Track Capital, LP

Bpifrance Participations SA

Bpifrance Participations SA

Deep Track Capital, LP

News Filter

Successfully Expands Access to Asia for Its Chikungunya Vaccine With Serum Institute of India

Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in the British Medical Journal

Reports Positive Three-Year Antibody Persistence Data for Its Single-Shot Chikungunya Vaccine IXCHIQ®

Submits Label Extension Application for Its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA to Potentially Include Adolescents and Antibody Persistence Up to Two Years

To Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

Proxies

No filings in this category.

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC